Wells Fargo
BSPM

Wells Fargo’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

Wells Fargo’s Portfolio BSPM Stock Details BSPM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-64
Closed – – 6013
2013
Q2 		$0 Buy
+64
New +$356 ﹤0.01% 5826

Other funds holding BSPM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo's BSPM Position: Q3 2013 in Review

Wells Fargo sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q3 2013, closing a stake of 64 shares.

Wells Fargo first reported a position in BSPM in Q2 2013 and held it in 1 quarter. The position peaked at $0 in Q2 2013. 5 funds tracked by Wall St. Rank hold BSPM as of Q3 2013.

  • Wells Fargo reported no remaining Biostar Pharmaceuticals, Inc. position as of Q3 2013 after selling out during the quarter.
  • Wells Fargo sold 64 Biostar Pharmaceuticals, Inc. shares in Q3 2013.
  • Wells Fargo first reported a position in Biostar Pharmaceuticals, Inc. in Q2 2013 and held it in 1 quarter.
  • Wells Fargo's Biostar Pharmaceuticals, Inc. position peaked at $0 in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q3 2013.

Based on Wells Fargo's 13F filing for Q3 2013, filed 13 Nov 2013.